quinoxalines has been researched along with 2,2'-(hydroxynitrosohydrazono)bis-ethanamine in 25 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (24.00) | 18.2507 |
| 2000's | 14 (56.00) | 29.6817 |
| 2010's | 5 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Drewett, JG; Herzig, TC; Knych, ET; Olson, LJ | 1 |
| Campbell, WB; Jin, MW; Li, PL | 1 |
| Campbell, WB; Drewett, JG; Hanke, CJ; Myers, CR | 1 |
| Bauer, PM; Buga, GM; Fukuto, JM; Ignarro, LJ; Wei, LH | 1 |
| Carlson, EJ; Drewett, JG; Kreklau, EL | 1 |
| Fernández-Tomé, P; Leza, JC; Lizasoain, I; Lorenzo, P; Moro, MA | 1 |
| Liu, XD; Rennard, SI; Romberger, DJ; Skold, CM; Spurzem, JR; Umino, T | 1 |
| Ellis, DZ; Nathanson, JA; Sweadner, KJ | 1 |
| Paterson, WG; Zhang, Y | 1 |
| Darley-Usmar, V; Murphy-Ullrich, JE; Poczatek, MH; Shiva, S; Wang, S | 1 |
| Gödecke, A; Nawrath, H; Schrader, J; Wegener, JW | 1 |
| Browner, NC; Lincoln, TM; Sellak, H | 1 |
| Beck, KF; Keller, T; McDonald, MC; Pfeilschifter, J; Plesková, M; Thiemermann, C | 1 |
| Bluysen, HA; Boer, P; Braam, B; de Roos, R; Dijk, A; Holstege, FC; Kemmeren, PP; Koomans, HA; Post, JA | 1 |
| Dorovini-Zis, K; Vincent, SR; Wong, D | 1 |
| Dorovini-Zis, K; Prameya, R; Vincent, SR; Wong, D; Wu, V | 1 |
| Espey, MG; Isenberg, JS; Ridnour, LA; Roberts, DD; Thomas, DD; Wink, DA | 1 |
| Dunkern, TR; Feurstein, D; Hatzelmann, A; Rossi, GA; Sabatini, F | 1 |
| Ishikawa, T; Nakayama, K; Noguchi, A; Takada, M | 1 |
| Chokshi, BM; Dismuke, WM; Ellis, DZ | 1 |
| Dou, D; Gao, Y; He, Q; Ma, H; Raj, JU; Wu, Y; Ying, L; Zheng, X | 1 |
| Altun, A; Bagcivan, I; Durmus, N; Sarac, B; Sencan, M; Turan, M | 1 |
| Agazatian, D; Froehlich, O; Kim, YH; Pech, V; Thumova, M; Verlander, JW; Wall, SM; Wang, X | 1 |
| Dismuke, WM; Liang, J; Overby, DR; Stamer, WD | 1 |
| Chen, Z; Dou, D; Gao, Y; Liu, H; Liu, J; Liu, L; Ye, L; Yu, X | 1 |
25 other study(ies) available for quinoxalines and 2,2'-(hydroxynitrosohydrazono)bis-ethanamine
| Article | Year |
|---|---|
Selective guanylyl cyclase inhibitor reverses nitric oxide-induced vasorelaxation.
Topics: Animals; Aorta; COS Cells; Cyclic GMP; Guanosine Triphosphate; Male; Muscle Relaxation; Muscle, Smooth, Vascular; Nitric Oxide; Nitroglycerin; Nitroso Compounds; Oxadiazoles; Oxidation-Reduction; Phenylephrine; Quinoxalines; Rats; Rats, Sprague-Dawley; Xanthine; Xanthine Oxidase; Xanthines | 1997 |
Effect of selective inhibition of soluble guanylyl cyclase on the K(Ca) channel activity in coronary artery smooth muscle.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adenosine; Animals; Cattle; Coronary Vessels; Cyclic GMP; Enzyme Inhibitors; Guanylate Cyclase; Iloprost; In Vitro Techniques; Kinetics; Membrane Potentials; Muscle Contraction; Muscle, Smooth, Vascular; Nitroso Compounds; Oxadiazoles; Patch-Clamp Techniques; Peptides; Potassium Channels; Quinoxalines; Scorpion Venoms; Vasodilation | 1998 |
Nitric oxide inhibits aldosterone synthesis by a guanylyl cyclase-independent effect.
Topics: Aldosterone; Animals; Atrial Natriuretic Factor; Bacterial Toxins; Cattle; Cells, Cultured; Cyclic GMP; Enterotoxins; Escherichia coli Proteins; Guanylate Cyclase; Humans; Nitric Oxide; Nitroso Compounds; Oxadiazoles; Pregnenolone; Quinoxalines; Zona Glomerulosa | 1998 |
NG-hydroxy-L-arginine and nitric oxide inhibit Caco-2 tumor cell proliferation by distinct mechanisms.
Topics: Animals; Aorta; Arginase; Arginine; Caco-2 Cells; Cell Division; Coculture Techniques; DNA; Endothelium, Vascular; Humans; Nitric Oxide; Nitric Oxide Donors; Ornithine; Ornithine Decarboxylase; Oxadiazoles; Polyamines; Putrescine; Quinoxalines; Rats; Spermidine; Spermine; Thymidine; Triazenes; Urea | 1998 |
Nitric oxide inhibits human aldosteronogenesis without guanylyl cyclase stimulation.
Topics: Adrenal Cortex; Aldosterone; Angiotensin II; Animals; Cell Line; Colforsin; Cyclic GMP; Enzyme Inhibitors; Guanylate Cyclase; Humans; Hydroxycholesterols; Nitric Oxide; Nitric Oxide Donors; Nitroprusside; Nitroso Compounds; Oxadiazoles; PC12 Cells; Quinoxalines; Rats | 1999 |
Neuroprotective effects of DETA-NONOate, a nitric oxide donor, on hydrogen peroxide-induced neurotoxicity in cortical neurones.
Topics: Animals; Animals, Newborn; Cell Survival; Cells, Cultured; Cerebral Cortex; Cyclic GMP; Enzyme Inhibitors; Hydrogen Peroxide; Neurons; Neuroprotective Agents; Nitric Oxide Donors; Nitroso Compounds; Oxadiazoles; Quinoxalines; Rats; Thionucleotides | 1999 |
Sodium nitroprusside augments human lung fibroblast collagen gel contraction independently of NO-cGMP pathway.
Topics: Animals; Cell Line; Collagen; Cyclic GMP; Dinoprostone; Enzyme Inhibitors; Fetus; Fibroblasts; Fibronectins; Gels; Humans; Lung; Nitric Oxide; Nitric Oxide Donors; Nitroprusside; Nitroso Compounds; Oxadiazoles; Penicillamine; Platelet Aggregation Inhibitors; Quinoxalines; Rats; Thionucleotides; Vasodilator Agents | 2000 |
Carbachol inhibits Na(+)-K(+)-ATPase activity in choroid plexus via stimulation of the NO/cGMP pathway.
Topics: Adenosine Triphosphate; Animals; Carbachol; Cattle; Cholinergic Agonists; Choroid Plexus; Cyclic GMP; Enzyme Inhibitors; Hydrolysis; In Vitro Techniques; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitroprusside; Ouabain; Oxadiazoles; Phosphorylation; Quinoxalines; Sodium-Potassium-Exchanging ATPase; Solubility; Thionucleotides; Triazenes; Vasodilator Agents | 2000 |
Nitric oxide contracts longitudinal smooth muscle of opossum oesophagus via excitation-contraction coupling.
Topics: Anesthetics, Local; Animals; Calcium Channel Blockers; Cyclic GMP; Enzyme Inhibitors; Esophagus; Female; In Vitro Techniques; Isometric Contraction; Male; Microelectrodes; Muscle, Smooth; Nifedipine; Nitric Oxide; Nitric Oxide Donors; Nitroprusside; Opossums; Oxadiazoles; Quinoxalines; Signal Transduction; Tetrodotoxin; Triazenes | 2001 |
Nitric oxide and cGMP-dependent protein kinase regulation of glucose-mediated thrombospondin 1-dependent transforming growth factor-beta activation in mesangial cells.
Topics: Animals; Cell Line; Cells, Cultured; Cyclic GMP; Cyclic GMP-Dependent Protein Kinases; Dose-Response Relationship, Drug; Down-Regulation; Enzyme Activation; Enzyme Inhibitors; Glomerular Mesangium; Glucose; Humans; Immunoblotting; Mink; Models, Biological; Nitric Oxide; Nitric Oxide Donors; Nitroso Compounds; Oxadiazoles; Plasminogen Activator Inhibitor 1; Promoter Regions, Genetic; Quinoxalines; Rats; RNA, Messenger; Signal Transduction; Thionucleotides; Thrombospondin 1; Time Factors; Transfection; Transforming Growth Factor beta | 2002 |
Effects of nitric oxide donors on cardiac contractility in wild-type and myoglobin-deficient mice.
Topics: Animals; Electric Stimulation; Enzyme Inhibitors; Female; Hydrazines; In Vitro Techniques; Male; Mice; Myocardial Contraction; Myocardium; Myoglobin; Nitric Oxide Donors; Nitrogen Oxides; Nitroso Compounds; Oxadiazoles; Quinoxalines; S-Nitroso-N-Acetylpenicillamine | 2002 |
Downregulation of cGMP-dependent protein kinase expression by inflammatory cytokines in vascular smooth muscle cells.
Topics: Animals; Aorta; Cattle; Cells, Cultured; Cyclic GMP-Dependent Protein Kinases; Down-Regulation; Enzyme Activators; Enzyme Inhibitors; Humans; Indazoles; Interleukin-1; Lipopolysaccharides; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Nitric Oxide Donors; Nitroso Compounds; Nucleotides, Cyclic; Oxadiazoles; Quinoxalines; Recombinant Proteins; Tumor Necrosis Factor-alpha | 2004 |
Identification of manganese superoxide dismutase as a NO-regulated gene in rat glomerular mesangial cells by 2D gel electrophoresis.
Topics: Animals; Blotting, Northern; Blotting, Western; Cyclic GMP; Electrophoresis, Gel, Two-Dimensional; Enzyme Inhibitors; Gene Expression Regulation, Enzymologic; Glomerular Mesangium; Lysine; Male; Nitric Oxide; Nitric Oxide Donors; Oxadiazoles; Quinoxalines; Rats; Rats, Wistar; RNA, Messenger; S-Nitroso-N-Acetylpenicillamine; Superoxide Dismutase; Triazenes; Up-Regulation | 2003 |
Nitric oxide donor induces temporal and dose-dependent reduction of gene expression in human endothelial cells.
Topics: Cell Survival; Cells, Cultured; Dose-Response Relationship, Drug; Drug Synergism; Endothelial Cells; Enzyme Inhibitors; Gene Expression; Guanylate Cyclase; Humans; Nitric Oxide; Nitric Oxide Donors; Nitroprusside; Nitroso Compounds; Oligonucleotide Array Sequence Analysis; Oxadiazoles; Quinoxalines; Time Factors; Transcription, Genetic | 2004 |
Cytokines, nitric oxide, and cGMP modulate the permeability of an in vitro model of the human blood-brain barrier.
Topics: Blood-Brain Barrier; Capillary Permeability; Cells, Cultured; Cyclic GMP; Cytokines; Electric Impedance; Endothelial Cells; Enzyme Inhibitors; Humans; Immunohistochemistry; In Vitro Techniques; Nitric Oxide; Nitric Oxide Donors; Nitroprusside; Nitroso Compounds; Oxadiazoles; Quinoxalines; Signal Transduction | 2004 |
Nitric oxide reduces T lymphocyte adhesion to human brain microvessel endothelial cells via a cGMP-dependent pathway.
Topics: Brain; Cell Adhesion; Cells, Cultured; Cyclic GMP; Dose-Response Relationship, Drug; E-Selectin; Endothelial Cells; Enzyme Inhibitors; Guanylate Cyclase; Humans; Intercellular Adhesion Molecule-1; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Donors; Nitric Oxide Synthase; Nitroprusside; Nitroso Compounds; Oxadiazoles; Platelet Endothelial Cell Adhesion Molecule-1; Quinoxalines; Signal Transduction; T-Lymphocytes; Tumor Necrosis Factor-alpha; Vascular Cell Adhesion Molecule-1 | 2005 |
Guanylyl cyclase-dependent chemotaxis of endothelial cells in response to nitric oxide gradients.
Topics: Cell Movement; Cells, Cultured; Chemotaxis; Diffusion; Endothelial Cells; Endothelium, Vascular; Guanylate Cyclase; Humans; Hydrazines; Neovascularization, Physiologic; Nitric Oxide; Nitrogen Oxides; Oxadiazoles; Quinoxalines; Triazenes; Volatilization | 2006 |
Inhibition of TGF-beta induced lung fibroblast to myofibroblast conversion by phosphodiesterase inhibiting drugs and activators of soluble guanylyl cyclase.
Topics: Actins; Benzamides; Benzoates; Blotting, Western; Cell Differentiation; Cells, Cultured; Cyclic GMP; Dinoprostone; Drug Synergism; Enzyme Activators; Fibroblasts; Fibrosis; Guanylate Cyclase; Humans; Immunohistochemistry; Isoenzymes; Lung; Myocytes, Smooth Muscle; Natriuretic Peptide, Brain; Nitric Oxide Donors; Nitroso Compounds; Oxadiazoles; Phosphodiesterase Inhibitors; Piperazines; Purines; Pyridines; Quinoxalines; Receptors, Cytoplasmic and Nuclear; Sildenafil Citrate; Soluble Guanylyl Cyclase; Sulfones; Transforming Growth Factor beta | 2007 |
cGMP-independent anti-apoptotic effect of nitric oxide on thapsigargin-induced apoptosis in the pancreatic beta-cell line INS-1.
Topics: Animals; Apoptosis; Cell Culture Techniques; Cell Line; Cyclic GMP; Dose-Response Relationship, Drug; Flow Cytometry; Insulin-Secreting Cells; Nitric Oxide; Nitric Oxide Donors; Oxadiazoles; Quinoxalines; Rats; Thapsigargin; Triazenes | 2008 |
Characterization of soluble guanylate cyclase in NO-induced increases in aqueous humor outflow facility and in the trabecular meshwork.
Topics: Adult; Aged, 80 and over; Animals; Aqueous Humor; Blotting, Western; Cell Culture Techniques; Cyclic GMP; Enzyme Activation; Enzyme Inhibitors; Guanylate Cyclase; Humans; Isoenzymes; Organ Culture Techniques; Oxadiazoles; Quinoxalines; Receptors, Cytoplasmic and Nuclear; Soluble Guanylyl Cyclase; Swine; Trabecular Meshwork; Triazenes | 2009 |
Increased degradation of MYPT1 contributes to the development of tolerance to nitric oxide in porcine pulmonary artery.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; 8-Bromo Cyclic Adenosine Monophosphate; Animals; Cyclic GMP; Enzyme Inhibitors; Lung; Myosin-Light-Chain Phosphatase; Nitric Oxide; Nitric Oxide Donors; Oxadiazoles; Protein Isoforms; Protein Phosphatase 1; Pulmonary Artery; Quinoxalines; Swine; Triazenes; Vasoconstrictor Agents | 2010 |
Investigation of relaxant effects of new agents affecting nitric oxide/cyclic guanosine monophosphate pathway on sheep oddi sphincter.
Topics: Animals; Carbachol; Cyclic GMP; Dose-Response Relationship, Drug; Guanylate Cyclase; In Vitro Techniques; Male; Molsidomine; Muscle Relaxation; Muscle, Smooth; Nitric Oxide; Oxadiazoles; Pyrazoles; Pyridines; Quinoxalines; Sheep; Sphincter of Oddi; Triazenes | 2010 |
Pendrin protein abundance in the kidney is regulated by nitric oxide and cAMP.
Topics: 8-Bromo Cyclic Adenosine Monophosphate; Animals; Anion Transport Proteins; Cells, Cultured; Colforsin; Cyclic AMP; Enzyme Inhibitors; Imidazoles; Kidney Tubules, Collecting; Mice; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Donors; Nitric Oxide Synthase; Nitroso Compounds; Oxadiazoles; Quinoxalines; Sulfate Transporters; Triazines | 2012 |
Concentration-related effects of nitric oxide and endothelin-1 on human trabecular meshwork cell contractility.
Topics: Adult; Cell Physiological Phenomena; Cells, Cultured; Cyclic GMP; Dose-Response Relationship, Drug; Endothelin-1; Enzyme Inhibitors; Guanylate Cyclase; Humans; Infant; Middle Aged; Myosin Light Chains; Nitric Oxide Donors; Nitroprusside; Oxadiazoles; Phosphorylation; Quinoxalines; Tissue Donors; Trabecular Meshwork; Triazenes | 2014 |
Preservation of nitric oxide-induced relaxation of porcine coronary artery: roles of the dimers of soluble guanylyl cyclase, phosphodiesterase type 5, and cGMP-dependent protein kinase.
Topics: Animals; Coronary Vessels; Cyclic GMP-Dependent Protein Kinases; Cyclic Nucleotide Phosphodiesterases, Type 5; Guanylate Cyclase; Nitric Oxide; Nitroso Compounds; Oxadiazoles; Phosphodiesterase 5 Inhibitors; Protein Kinase Inhibitors; Protein Multimerization; Purinones; Quinoxalines; Swine; Vasodilation | 2014 |